1	The	the	DT	_	2	det	_
2	boss	boss	NN	_	5	nsubj	5:A0
3	of	of	IN	_	2	prep	_
4	AstraZeneca	astrazeneca	NNP	_	3	pobj	_
5	said	say	VBD	pb=say.01	0	root	_
6	there	there	EX	_	7	expl	_
7	was	be	VBD	pb=be.02	5	ccomp	5:A1=PPT
8	no	no	DT	_	9	det	_
9	prospect	prospect	NN	_	7	attr	7:A1=PPT
10	of	of	IN	_	9	prep	_
11	a	a	DT	_	12	det	_
12	deal	deal	NN	_	10	pobj	_
13	with	with	IN	_	12	prep	_
14	US	us	NNP	_	16	nn	_
15	drug	drug	NN	_	16	nn	_
16	giant	giant	NN	p2=JJ	17	nn	_
17	Pfizer	pfizer	NNP	p2=NN	13	pobj	_
18	before	before	IN	_	7	prep	_
19	a	a	DT	_	21	det	_
20	set	set	NN	p2=VBN	21	nn	_
21	deadline	deadline	NN	_	18	pobj	_
22	of	of	IN	_	21	prep	_
23	May	may	NNP	_	22	pobj	_
24	26	0	CD	_	23	num	_
25	.	.	.	_	5	punct	_

1	Chairman	chairman	NNP	p2=NN	3	nn	_
2	Leif	leif	NNP	_	3	nn	_
3	Johansson	johansson	NNP	_	5	nsubj	5:A0
4	also	also	RB	_	5	advmod	5:AM-DIS
5	said	say	VBD	pb=say.01	0	root	_
6	there	there	EX	_	7	expl	_
7	was	be	VBD	pb=be.02	5	ccomp	5:A1=PPT
8	no	no	DT	_	9	det	_
9	likelihood	likelihood	NN	_	7	attr	7:A1=PPT
10	of	of	IN	_	9	prep	_
11	a	a	DT	_	13	det	_
12	deadline	deadline	NN	_	13	nn	_
13	extension	extension	NN	_	10	pobj	_
14	,	,	,	_	17	punct	_
15	under	under	IN	_	9	prep	_
16	rules	rule	NNS	_	15	pobj	17:A1=PPT
17	laid	lay	VBN	p2=VBD|pb=lay.01	16	partmod	_
18	down	down	RP	_	17	prt	17:AM-ADV
19	by	by	IN	_	17	agent	17:A0=PAG
20	the	the	DT	_	22	det	_
21	Takeover	takeover	NN	p2=NNP	22	nn	_
22	Panel	panel	NNP	p2=NN	19	pobj	_
23	.	.	.	_	5	punct	_

1	Mr	mr	NNP	_	2	nn	_
2	Johansson	johansson	NNP	_	3	nsubj	3:A0
3	said	say	VBD	pb=say.01	0	root	_
4	that	that	IN	_	6	complm	_
5	it	it	PRP	_	6	nsubj	6:A1=PPT
6	was	be	VBD	pb=be.01	3	ccomp	3:A1=PPT
7	Pfizer	pfizer	NNP	_	6	attr	13:A0=PAG;6:A2=PRD
8	,	,	,	_	7	punct	_
9	not	not	RB	_	7	neg	_
10	AstraZeneca	astrazeneca	NNP	_	7	appos	_
11	,	,	,	_	7	punct	_
12	that	that	WDT	p2=DT	13	nsubj	13:R-A0
13	called	call	VBD	pb=call.03	7	rcmod	_
14	an	an	DT	_	15	det	_
15	end	end	NN	_	13	dobj	13:A1=PPT
16	to	to	IN	_	15	prep	_
17	discussions	discussion	NNS	_	16	pobj	_
18	on	on	IN	_	17	prep	_
19	Sunday	sunday	NNP	_	20	nn	_
20	afternoon	afternoon	NN	_	18	pobj	_
21	about	about	IN	_	17	prep	_
22	a	a	DT	_	24	det	_
23	potential	potential	JJ	_	24	amod	_
24	takeover	takeover	NN	_	21	pobj	_
25	to	to	TO	_	26	aux	_
26	create	create	VB	pb=create.01	13	advcl	13:AM-PRP
27	the	the	DT	_	28	det	_
28	world	world	NN	_	32	poss	_
29	's	's	POS	_	28	possessive	_
30	largest	large	JJS	_	32	amod	_
31	drug	drug	NN	_	32	nn	_
32	maker	maker	NN	_	26	dobj	26:A1=PPT
33	.	.	.	_	3	punct	_

1	Early	early	RB	_	5	advmod	5:AM-TMP
2	Monday	monday	NNP	_	3	nn	_
3	morning	morning	NN	_	4	nn	_
4	AstraZeneca	astrazeneca	NNP	_	5	nsubj	5:A0=PAG
5	announced	announce	VBD	pb=announce.01	0	root	_
6	a	a	DT	_	7	det	_
7	rejection	rejection	NN	_	5	dobj	5:A1=PPT
8	of	of	IN	_	7	prep	_
9	Pfizer	pfizer	NNP	_	16	poss	_
10	's	's	POS	_	9	possessive	_
11	"	"	``	_	13	punct	_
12	final	final	JJ	_	13	amod	_
13	offer	offer	NN	_	16	nn	_
14	"	"	''	_	13	punct	_
15	takeover	takeover	NN	_	16	nn	_
16	bid	bid	NN	_	8	pobj	19:A0
17	,	,	,	_	16	punct	_
18	which	which	WDT	_	19	nsubj	19:R-A0
19	valued	value	VBD	pb=value.01	16	rcmod	_
20	the	the	DT	_	21	det	_
21	company	company	NN	_	19	dobj	19:A1
22	at	at	IN	_	19	prep	19:A2=PRD
23	£69.3bn	£69.3bn	NNP	p2=CD	22	pobj	_
24	(	(	-LRB-	_	23	punct	_
25	$	$	$	p2=``	26	nmod	_
26	119bn	0bn	CD	p2=NNP	23	appos	_
27	)	)	-RRB-	_	23	punct	_
28	.	.	.	_	5	punct	_

1	The	the	DT	_	4	det	_
2	British	british	JJ	_	4	amod	_
3	drug	drug	NN	_	4	nn	_
4	firm	firm	NN	_	5	nsubj	5:A0
5	said	say	VBD	pb=say.01	0	root	_
6	the	the	DT	_	7	det	_
7	offer	offer	NN	_	12	nsubj	12:A1=PPT
8	of	of	IN	_	7	prep	_
9	£55	£0	CD	p2=PDT	8	pobj	_
10	a	a	DT	_	11	det	_
11	share	share	NN	_	9	npadvmod	_
12	falls	fall	VBZ	pb=fall.01	5	ccomp	5:A1=PPT
13	short	short	JJ	_	12	advmod	12:A2=EXT
14	of	of	IN	_	13	prep	_
15	its	its	PRP$	_	16	poss	_
16	value	value	NN	_	14	pobj	_
17	as	as	IN	_	16	prep	_
18	an	an	DT	_	20	det	_
19	independent	independent	JJ	_	20	amod	_
20	company	company	NN	_	17	pobj	_
21	and	and	CC	_	12	cc	_
22	that	that	IN	p2=WDT	28	mark	_
23	its	its	PRP$	_	26	poss	_
24	larger	large	JJR	_	26	amod	_
25	US	us	NNP	_	26	nn	_
26	rival	rival	NN	p2=RB	28	nsubj	31:A0=PAG;28:A1=PAG
27	had	have	VBD	_	28	aux	_
28	failed	fail	VBN	pb=fail.01	17	conj	_
29	to	to	TO	_	31	aux	_
30	"	"	``	_	31	punct	_
31	make	make	VB	pb=make.05	28	xcomp	28:A2=PPT
32	a	a	DT	_	35	det	_
33	compelling	compelling	JJ	_	35	amod	_
34	strategic	strategic	JJ	_	35	amod	_
35	business	business	NN	_	38	nn	_
36	or	or	CC	_	35	cc	_
37	value	value	NN	_	35	conj	_
38	case	case	NN	_	31	dobj	31:A1=PPT
39	"	"	''	_	31	punct	_
40	.	.	.	_	5	punct	_

1	It	it	PRP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	the	the	DT	_	5	det	_
4	Pfizer	pfizer	NNP	_	5	nn	_
5	proposals	proposal	NNS	_	7	nsubj	7:A0=PAG
6	would	would	MD	_	7	aux	7:AM-MOD
7	bring	bring	VB	pb=bring.01	2	ccomp	2:A1=PPT
8	"	"	``	_	7	punct	_
9	uncertainty	uncertainty	NN	_	7	dobj	7:A1=PPT
10	and	and	CC	_	9	cc	_
11	risks	risk	NNS	p2=VBZ	9	conj	_
12	"	"	''	p2=``	7	punct	_
13	for	for	IN	_	7	prep	7:A2=GOL
14	AstraZeneca	astrazeneca	NNP	p2=JJ	15	nn	_
15	shareholders	shareholder	NNS	_	13	pobj	_
16	.	.	.	_	2	punct	_

1	Mr	mr	NNP	p2=NN	2	nn	_
2	Johansson	johansson	NNP	_	3	nsubj	3:A0=PAG
3	told	tell	VBD	pb=tell.01	0	root	_
4	Sky	sky	NNP	_	5	nn	_
5	News	news	NNP	p2=NN	3	dobj	3:A1=PPT
6	:	:	:	_	3	punct	_
7	"	"	``	_	3	punct	_
8	We	we	PRP	_	9	nsubj	9:A0=PAG
9	rejected	reject	VBD	pb=reject.01	3	ccomp	_
10	the	the	DT	_	11	det	_
11	bid	bid	NN	_	9	dobj	9:A1=PPT
12	on	on	IN	_	11	prep	_
13	three	#crd#	CD	_	14	num	_
14	grounds	ground	NNS	_	12	pobj	_
15	.	.	.	_	3	punct	_

1	First	#ord#	RB	_	4	advmod	4:AM-DIS
2	,	,	,	_	4	punct	_
3	we	we	PRP	_	4	nsubj	4:A0
4	think	think	VBP	pb=think.01	0	root	_
5	it	it	PRP	_	6	nsubj	6:A0=PAG
6	undervalues	undervalue	VBZ	pb=undervalue.01	4	ccomp	4:A1=PPT
7	the	the	DT	_	8	det	_
8	opportunities	opportunity	NNS	_	6	dobj	6:A1=PPT
9	we	we	PRP	_	10	nsubj	10:A0
10	think	think	VBP	pb=think.01	8	rcmod	_
11	AstraZeneca	astrazeneca	NNP	_	13	nsubj	13:A0=PAG
12	could	could	MD	_	13	aux	13:AM-MOD
13	have	have	VB	pb=have.03	10	ccomp	10:A1=PPT
14	as	as	IN	p2=RB	13	prep	13:AM-PRD
15	an	an	DT	_	17	det	_
16	independent	independent	JJ	p2=NN	17	amod	_
17	company	company	NN	_	14	pobj	_
18	.	.	.	_	4	punct	_
19	"	"	''	_	4	punct	_

1	Secondly	secondly	RB	_	4	advmod	4:AM-DIS
2	,	,	,	_	4	punct	_
3	we	we	PRP	_	4	nsubj	4:A0
4	think	think	VBP	pb=think.01	0	root	_
5	there	there	EX	p2=RB	6	expl	_
6	is	be	VBZ	pb=be.02	4	ccomp	4:A1=PPT
7	a	a	DT	_	13	det	_
8	long	long	JJ	_	13	amod	_
9	,	,	,	_	13	punct	_
10	drawn	draw	VBN	_	12	hmod	_
11	-	-	HYPH	_	12	hyph	_
12	out	out	RP	_	13	amod	_
13	process	process	NN	_	6	attr	6:A1=PPT
14	,	,	,	_	6	punct	_
15	with	with	IN	_	6	prep	_
16	very	very	RB	_	17	advmod	_
17	considerable	considerable	JJ	_	19	amod	_
18	execution	execution	NN	_	19	nn	_
19	risk	risk	NN	_	15	pobj	_
20	...	..	.	p2=:	4	punct	_

1	and	and	CC	_	5	cc	5:AM-DIS
2	thirdly	thirdly	RB	_	5	advmod	5:AM-DIS
3	,	,	,	_	5	punct	_
4	we	we	PRP	_	5	nsubj	5:A0
5	think	think	VBP	pb=think.01	0	root	_
6	there	there	EX	_	7	expl	_
7	is	be	VBZ	pb=be.02	5	ccomp	5:A1=PPT
8	a	a	DT	_	11	det	_
9	clearly	clearly	RB	_	10	advmod	_
10	disruptive	disruptive	JJ	_	11	amod	_
11	element	element	NN	_	7	attr	7:A1=PPT
12	in	in	IN	_	11	prep	_
13	how	how	WRB	_	17	advmod	17:R-AM-MNR
14	we	we	PRP	_	17	nsubj	17:A0=PAG
15	can	can	MD	_	17	aux	17:AM-MOD
16	best	well	RBS	p2=RB	17	advmod	17:AM-MNR
17	create	create	VB	pb=create.01	12	pcomp	_
18	value	value	NN	_	17	dobj	17:A1=PPT
19	for	for	IN	_	18	prep	_
20	shareholders	shareholder	NNS	_	19	pobj	_
21	and	and	CC	_	20	cc	_
22	society	society	NN	_	20	conj	_
23	by	by	IN	_	17	prep	17:AM-MNR
24	disrupting	disrupt	VBG	pb=disrupt.01	23	pcomp	_
25	the	the	DT	_	26	det	_
26	way	way	NN	_	24	dobj	24:A1=PPT;28:AM-MNR
27	we	we	PRP	_	28	nsubj	28:A0=PAG
28	get	get	VBP	pb=get.01	26	rcmod	_
29	medicines	medicine	NNS	_	28	dobj	28:A1=PPT
30	to	to	IN	_	28	prep	_
31	the	the	DT	_	32	det	_
32	market	market	NN	_	30	pobj	_
33	.	.	.	_	5	punct	_

1	"	"	``	p2=''	8	punct	_
2	On	on	IN	p2=NNP	8	prep	8:AM-TMP
3	Sunday	sunday	NNP	_	2	pobj	_
4	,	,	,	_	8	punct	_
5	Pfizer	pfizer	NNP	_	6	nn	_
6	told AstraZeneca	told astrazeneca	NNP	p2=VBD	16	nsubj	_
7	it	it	PRP	_	8	nsubj	8:A0=PAG
8	had	have	VBD	pb=have.03	0	root	_
9	until	until	IN	_	8	prep	8:AM-TMP
10	5	0	CD	_	11	num	_
11	pm	pm	NN	_	9	pobj	_
12	on	on	IN	_	11	prep	_
13	May	may	NNP	_	12	pobj	_
14	26	0	CD	_	13	num	_
15	to	to	TO	_	16	aux	_
16	make	make	VB	pb=make.05	8	xcomp	_
17	a	a	DT	_	18	det	_
18	decision	decision	NN	_	16	dobj	16:AM-PRR
19	.	.	.	_	8	punct	_

1	Mr	mr	NNP	_	2	nn	_
2	Johansson	johansson	NNP	_	3	nsubj	3:A0
3	said	say	VBD	pb=say.01	0	root	_
4	he	he	PRP	_	7	nsubj	7:A0=PAG
5	had	have	VBD	_	7	aux	_
6	had	have	VBN	_	7	aux	_
7	made	make	VBN	pb=make.02	3	ccomp	3:A1=PPT
8	it	it	PRP	_	9	nsubj	_
9	clear	clear	JJ	_	7	ccomp	7:A1=PRD
10	that	that	IN	_	15	complm	_
11	his	his	PRP$	_	12	poss	_
12	board	board	NN	_	15	nsubj	15:A0=PAG
13	could	could	MD	_	15	aux	15:AM-MOD
14	only	only	RB	_	15	advmod	15:AM-ADV
15	recommend	recommend	VB	pb=recommend.01	9	advcl	_
16	a	a	DT	_	17	det	_
17	bid	bid	NN	_	15	dobj	15:A1=PPT;19:A1=PPT
18	that	that	WDT	p2=DT	19	nsubj	19:R-A1
19	was	be	VBD	pb=be.01	17	rcmod	_
20	at	at	IN	p2=RB	21	advmod	_
21	least	least	RBS	p2=JJS	22	advmod	_
22	10	0	CD	_	23	num	_
23	%	%	NN	_	24	npadvmod	_
24	above	above	IN	_	19	prep	19:A2=PRD
25	an	an	DT	_	26	det	_
26	offer	offer	NN	_	24	pobj	_
27	of	of	IN	_	26	prep	_
28	£53.50	£0	NNS	p2=NN	27	pobj	29:A1=PRD
29	made	make	VBN	pb=make.01	28	partmod	_
30	by	by	IN	_	29	agent	29:A0=PAG
31	Pfizer	pfizer	NNP	_	30	pobj	_
32	on	on	IN	_	29	prep	29:AM-TMP
33	Friday	friday	NNP	_	34	nn	_
34	evening	evening	NN	_	32	pobj	_
35	.	.	.	_	3	punct	_

1	AstraZeneca	astrazeneca	NNP	p2=JJ	2	nn	_
2	shares	share	NNS	_	3	nsubj	3:A1=PPT
3	plunged	plunge	VBD	p2=VBN|pb=plunge.02	0	root	_
4	by	by	IN	_	3	prep	3:A2=LOC
5	more	more	JJR	_	7	amod	_
6	than	than	IN	_	7	quantmod	_
7	14	0	CD	_	8	num	_
8	%	%	NN	_	4	pobj	_
9	in	in	IN	_	3	prep	3:AM-TMP
10	early	early	JJ	_	12	amod	_
11	Monday	monday	NNP	_	12	nn	_
12	trading	trading	NN	_	9	pobj	_
13	,	,	,	_	3	punct	_
14	driving	drive	VBG	pb=drive.02	3	advcl	3:AM-ADV
15	its	its	PRP$	_	17	poss	_
16	market	market	NN	_	17	nn	_
17	value	value	NN	_	14	dobj	14:A1=PPT
18	down	down	IN	p2=RB	14	advmod	14:A2=PRD
19	to	to	IN	_	18	prep	_
20	£52.1bn	£0bn	CD	p2=NNP	19	pobj	_
21	,	,	,	_	20	punct	_
22	£17bn	£0bn	CD	p2=IN	23	npadvmod	_
23	less	less	JJR	_	20	amod	_
24	than	than	IN	_	23	prep	_
25	the	the	DT	_	26	det	_
26	value	value	NN	_	24	pobj	29:A1=PPT
27	Pfizer	pfizer	NNP	_	29	nsubj	29:A0=PAG
28	had	have	VBD	_	29	aux	_
29	put	put	VBN	pb=put.01	26	rcmod	_
30	on	on	IN	_	29	prep	29:A2=GOL
31	the	the	DT	_	32	det	_
32	company	company	NN	_	30	pobj	_
33	.	.	.	_	3	punct	_

1	On	on	IN	_	10	prep	10:AM-TMP
2	May	may	NNP	_	1	pobj	_
3	2	0	CD	_	2	num	_
4	,	,	,	_	10	punct	_
5	New	new	NNP	_	6	nn	_
6	York	york	NNP	p2=NN	8	hmod	_
7	-	-	HYPH	_	8	hyph	_
8	based	base	VBN	_	9	amod	_
9	Pfizer	pfizer	NNP	_	10	nsubj	10:A0=PAG
10	made	make	VBD	pb=make.01	0	root	_
11	an	an	DT	_	12	det	_
12	offer	offer	NN	_	10	dobj	24:A1;10:AM-PRR
13	of	of	IN	_	12	prep	_
14	£63bn	£63bn	NNP	p2=NN	19	nn	_
15	(	(	-LRB-	_	14	punct	_
16	$	$	$	p2=``	17	nmod	_
17	106bn	0bn	CD	p2=NNP	14	appos	_
18	)	)	-RRB-	_	19	punct	_
19	 for AstraZeneca	 for astrazeneca	NNP	p2=NN	13	pobj	_
20	,	,	,	_	12	punct	_
21	which	which	WDT	_	24	dobj	24:R-A1
22	the	the	DT	_	23	det	_
23	board	board	NN	_	24	nsubj	24:A0=PAG
24	rejected	reject	VBD	p2=VBN|pb=reject.01	12	rcmod	_
25	"	"	``	_	24	punct	_
26	without	without	IN	_	24	prep	24:AM-MNR
27	hesitation	hesitation	NN	_	26	pobj	_
28	"	"	''	_	24	punct	_
29	.	.	.	_	10	punct	_

1	Investors	investor	NNS	_	2	nsubj	2:A0=PAG;5:A0=PAG
2	backed	back	VBD	p2=VBN|pb=back.01	0	root	_
3	AstraZeneca	astrazeneca	NNP	_	2	dobj	2:A1=PPT
4	in	in	IN	_	2	prep	2:AM-MNR
5	rejecting	reject	VBG	pb=reject.01	4	pcomp	_
6	the	the	DT	_	12	det	_
7	cash	cash	NN	_	12	nn	_
8	-	-	HYPH	_	7	hyph	_
9	and	and	CC	_	7	cc	_
10	-	-	HYPH	_	11	hyph	_
11	stock	stock	NN	_	7	conj	_
12	approach	approach	NN	_	5	dobj	5:A1=PPT
13	worth	worth	JJ	p2=NN	12	amod	_
14	£50	£0	IN	p2=,	12	prep	_
15	a	a	DT	_	16	det	_
16	share	share	NN	_	14	pobj	_
17	,	,	,	_	2	punct	_
18	but	but	CC	_	2	cc	_
19	many	many	JJ	_	20	nsubj	20:A0
20	said	say	VBD	pb=say.01	2	conj	_
21	they	they	PRP	_	23	nsubj	23:A0=PAG
22	would	would	MD	_	23	aux	23:AM-MOD
23	want	want	VB	pb=want.01	20	ccomp	20:A1=PPT
24	it	it	PRP	_	26	nsubj	26:A0=PAG
25	to	to	TO	_	26	aux	_
26	engage	engage	VB	pb=engage.01	23	ccomp	23:A1=PPT
27	if	if	IN	_	29	mark	_
28	Pfizer	pfizer	NNP	_	29	nsubj	29:A1=PPT
29	came	come	VBD	pb=come.01	26	advcl	26:AM-ADV
30	back	back	RB	p2=RP	29	advmod	29:AM-DIR
31	with	with	IN	_	29	prep	29:AM-MNR
32	an	an	DT	_	34	det	_
33	improved	improved	JJ	p2=VBN	34	amod	_
34	offer	offer	NN	_	31	pobj	_
35	.	.	.	_	20	punct	_

1	Pfizer	pfizer	NNP	_	3	nsubj	3:A0;19:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	said	say	VBD	p2=VBN|pb=say.01	0	root	_
4	it	it	PRP	_	7	nsubj	7:A0=PAG
5	will	will	MD	_	7	aux	7:AM-MOD
6	not	not	RB	_	7	neg	7:AM-NEG
7	make	make	VB	pb=make.02	3	ccomp	3:A1=PPT
8	a	a	DT	_	10	det	_
9	hostile	hostile	JJ	_	10	amod	_
10	offer	offer	NN	_	7	dobj	7:AM-PRR
11	directly	directly	RB	_	7	advmod	7:AM-MNR
12	to	to	IN	_	7	prep	7:A1=PRD
13	AstraZeneca	astrazeneca	NNP	_	14	nn	_
14	shareholders	shareholder	NNS	_	12	pobj	_
15	,	,	,	_	3	punct	_
16	and	and	CC	_	3	cc	_
17	would	would	MD	_	19	aux	19:AM-MOD
18	only	only	RB	_	19	advmod	19:AM-ADV
19	proceed	proceed	VB	pb=proceed.01	3	conj	_
20	with	with	IN	_	19	prep	19:A1=PPT
21	an	an	DT	_	22	det	_
22	offer	offer	NN	_	20	pobj	_
23	with	with	IN	_	22	prep	_
24	the	the	DT	_	25	det	_
25	recommendation	recommendation	NN	_	23	pobj	_
26	of	of	IN	_	25	prep	_
27	AstraZeneca	astrazeneca	NNP	_	29	poss	_
28	's	's	POS	_	27	possessive	_
29	board	board	NN	_	26	pobj	_
30	.	.	.	_	3	punct	_

1	Sky	sky	NNP	_	3	nn	_
2	News	news	NNP	_	3	nn	_
3	City	city	NNP	_	6	nn	_
4	Editor	editor	NNP	_	6	nn	_
5	Mark	mark	NNP	_	6	nn	_
6	Kleinman	kleinman	NNP	_	7	nsubj	7:A0
7	said	say	VBD	pb=say.01	0	root	_
8	:	:	:	_	7	punct	_
9	"	"	``	_	7	punct	_
10	The	the	DT	_	12	det	_
11	AstraZeneca	astrazeneca	NNP	_	12	nn	_
12	board	board	NN	_	14	nsubj	14:A0=PAG
13	has	have	VBZ	_	14	aux	_
14	highlighted	highlight	VBN	pb=highlight.01	7	ccomp	7:A1=PPT
15	the	the	DT	_	17	det	_
16	inherent	inherent	JJ	_	17	amod	_
17	risks	risk	NNS	_	14	dobj	14:A1=PPT
18	in	in	IN	_	17	prep	_
19	doing	do	VBG	pb=do.02	18	pcomp	_
20	a	a	DT	_	21	det	_
21	deal	deal	NN	_	19	dobj	19:A1=PPT
22	with	with	IN	_	21	prep	_
23	Pfizer	pfizer	NNP	_	22	pobj	_
24	at	at	IN	_	19	prep	19:AM-MNR
25	any	any	DT	_	26	det	_
26	price	price	NN	_	24	pobj	_
27	-	-	:	p2=,	23	punct	_
28	the	the	DT	_	29	det	_
29	risk	risk	NN	_	26	appos	_
30	to	to	IN	_	29	prep	_
31	jobs	job	NNS	_	30	pobj	35:A1=PPT
32	that	that	WDT	p2=DT	35	nsubjpass	35:R-A1
33	would	would	MD	_	35	aux	35:AM-MOD
34	be	be	VB	_	35	auxpass	_
35	triggered	trigger	VBN	pb=trigger.01	31	rcmod	_
36	from	from	IN	_	35	prep	_
37	a	a	DT	_	38	det	_
38	merger	merger	NN	_	36	pobj	_
39	of	of	IN	_	38	prep	_
40	this	this	DT	_	41	det	_
41	kind	kind	NN	_	39	pobj	_
42	.	.	.	_	7	punct	_

1	"	"	``	_	11	punct	_
2	But	but	CC	_	11	cc	11:AM-DIS
3	unusually	unusually	RB	_	4	advmod	_
4	in	in	IN	p2=RB	11	prep	11:AM-LOC
5	AstraZeneca	astrazeneca	NNP	_	7	poss	_
6	's	's	POS	_	5	possessive	_
7	statement	statement	NN	_	4	pobj	_
8	,	,	,	_	11	punct	_
9	it	it	PRP	_	11	nsubj	11:A0=PAG
10	has	have	VBZ	_	11	aux	_
11	put	put	VBN	pb=put.01	0	root	_
12	a	a	DT	_	14	det	_
13	price	price	NN	_	14	nn	_
14	tag	tag	NN	_	11	dobj	11:A1=PPT
15	on	on	IN	_	11	prep	11:A2=GOL
16	itself	itself	PRP	_	15	pobj	_
17	...	..	.	p2=NFP	11	punct	_

1	it	it	PRP	_	2	nsubj	2:A0
2	says	say	VBZ	pb=say.01	0	root	_
3	it	it	PRP	_	6	nsubj	9:A0;6:A1=PPT
4	would	would	MD	_	6	aux	6:AM-MOD
5	only	only	RB	_	6	advmod	6:AM-ADV
6	be	be	VB	pb=be.01	2	ccomp	2:A1=PPT
7	prepared	prepared	JJ	p2=VBN	6	acomp	6:A2=PRD
8	to	to	TO	_	9	aux	_
9	make	make	VB	pb=make.LV	7	xcomp	_
10	a	a	DT	_	11	det	_
11	recommendation	recommendation	NN	_	9	dobj	9:AM-PRR
12	to	to	IN	_	11	prep	_
13	shareholders	shareholder	NNS	_	12	pobj	_
14	if	if	IN	_	19	mark	_
15	the	the	DT	_	16	det	_
16	board	board	NN	_	19	nsubj	19:A1=PPT
17	of	of	IN	_	16	prep	_
18	Pfizer	pfizer	NNP	_	17	pobj	_
19	were	be	VBD	pb=be.01	6	advcl	6:AM-ADV
20	to	to	TO	_	21	aux	_
21	make	make	VB	pb=make.02	19	xcomp	19:A2=PRD
22	an	an	DT	_	23	det	_
23	offer	offer	NN	_	21	dobj	25:A1=PPT;21:AM-PRR
24	that	that	WDT	p2=DT	25	nsubj	25:R-A1
25	was	be	VBD	pb=be.01	23	rcmod	_
26	at	at	IN	p2=RB	27	advmod	_
27	least	least	RBS	p2=JJS	28	advmod	_
28	10	0	CD	_	29	num	_
29	%	%	NN	_	30	npadvmod	_
30	above	above	IN	_	25	prep	25:A2=PRD
31	the	the	DT	_	32	det	_
32	£53.50	£0	NN	p2=CD	30	pobj	37:A1=PRD
33	per	per	IN	_	32	prep	_
34	share	share	NN	_	33	pobj	_
35	that	that	WDT	_	37	nsubjpass	37:R-A1
36	was	be	VBD	_	37	auxpass	_
37	made	make	VBN	pb=make.01	32	rcmod	_
38	privately	privately	RB	_	37	advmod	37:AM-MNR
39	on	on	IN	_	37	prep	37:AM-TMP
40	Friday	friday	NNP	_	39	pobj	_
41	.	.	.	_	2	punct	_
42	"	"	''	_	2	punct	_

1	That	that	DT	_	3	nsubj	3:A0=PAG
2	would	would	MD	_	3	aux	3:AM-MOD
3	put	put	VB	pb=put.01	0	root	_
4	a	a	DT	_	6	det	_
5	price	price	NN	_	6	nn	_
6	tag	tag	NN	_	3	dobj	3:A1=PPT
7	on	on	IN	_	3	prep	3:A2=GOL
8	AstraZeneca	astrazeneca	NNP	_	7	pobj	_
9	of	of	IN	_	8	prep	_
10	about	about	IN	p2=RB	11	advmod	_
11	£59	£0	CD	p2=PDT	9	pobj	_
12	a	a	DT	_	15	det	_
13	share	share	NN	_	15	hmod	_
14	-	-	HYPH	p2=,	15	hyph	_
15	well	well	NN	p2=RB	3	dobj	_
16	over	over	IN	_	15	prep	_
17	£70bn	£0bn	NN	p2=NNP	16	pobj	_
18	.	.	.	_	3	punct	_

1	"	"	``	_	6	punct	_
2	The	the	DT	_	5	det	_
3	latest	late	JJS	p2=RBS	5	amod	_
4	rejected	reject	VBN	p2=VBD|pb=reject.01	5	amod	_
5	bid	bid	NN	p2=VBD	6	nsubj	6:A0=PAG;4:A1=PPT
6	increased	increase	VBD	pb=increase.01	0	root	_
7	the	the	DT	_	9	det	_
8	cash	cash	NN	_	9	nn	_
9	element	element	NN	_	6	dobj	6:A1=PPT
10	to	to	IN	_	6	prep	6:A4=GOL
11	45	0	CD	_	12	num	_
12	%	%	NN	_	10	pobj	_
13	,	,	,	_	6	punct	_
14	with	with	IN	_	6	prep	6:AM-ADV
15	AstraZeneca	astrazeneca	NNP	p2=JJ	16	nn	_
16	shareholders	shareholder	NNS	_	17	nsubj	17:A0=PAG;19:A0=PAG
17	set	set	VBN	p2=VBP|pb=set.08	14	pcomp	_
18	to	to	TO	_	19	aux	_
19	receive	receive	VB	pb=receive.01	17	xcomp	17:A1=PPT
20	1.747	0	CD	_	21	num	_
21	shares	share	NNS	_	19	dobj	19:A1=PPT
22	in	in	IN	_	19	prep	19:AM-LOC
23	the	the	DT	_	25	det	_
24	enlarged	enlarged	JJ	p2=VBN	25	amod	_
25	company	company	NN	_	22	pobj	_
26	for	for	IN	_	19	prep	19:A3
27	each	each	DT	_	26	pobj	_
28	of	of	IN	_	27	prep	_
29	their	their	PRP$	_	31	poss	_
30	AstraZeneca	astrazeneca	NNP	p2=JJ	31	nn	_
31	shares	share	NNS	_	28	pobj	_
32	and	and	CC	_	17	cc	_
33	2.476p	0p	CD	p2=LS	17	conj	_
34	in	in	IN	p2=RP	33	prep	_
35	cash	cash	NN	_	34	pobj	_
36	.	.	.	_	6	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0=PAG;4:A0=PAG
2	wants	want	VBZ	pb=want.01	0	root	_
3	to	to	TO	_	4	aux	_
4	create	create	VB	pb=create.01	2	xcomp	2:A1=PPT
5	the	the	DT	_	6	det	_
6	world	world	NN	_	10	poss	_
7	's	's	POS	_	6	possessive	_
8	largest	large	JJS	_	10	amod	_
9	drugs	drug	NNS	_	10	nn	_
10	company	company	NN	_	4	dobj	4:A1=PPT
11	,	,	,	_	4	punct	_
12	with	with	IN	_	4	prep	_
13	its	its	PRP$	_	14	poss	_
14	headquarters	headquarters	NN	p2=NNS	12	pobj	_
15	in	in	IN	_	14	prep	_
16	New	new	NNP	_	17	nn	_
17	York	york	NNP	_	15	pobj	_
18	and	and	CC	_	14	cc	_
19	a	a	DT	_	21	det	_
20	tax	tax	NN	_	21	nn	_
21	base	base	NN	_	14	conj	_
22	in	in	IN	_	21	prep	_
23	Britain	britain	NNP	_	22	pobj	_
24	.	.	.	_	2	punct	_

